Literature DB >> 1890562

Individual differences in tumour necrosis factor and interleukin-1 production induced by viable and heat-killed Candida albicans.

J Jeremias1, A Kalo-Klein, S S Witkin.   

Abstract

The in vitro production of tumour necrosis factor (TNF) and interleukin-1 (IL-1) by peripheral blood mononuclear cells from 27 healthy women in response to viable and heat-killed Candida albicans was measured. Production of both cytokines was proportional to the concentration of viable C. albicans and increased at a steady rate for at least 24 h. No relationship was observed between the levels of IL-1 and TNF produced by the mononuclear cells from any individual. Some women were high TNF producers and low IL-1 producers or vice versa. Higher levels of TNF were induced by heat-killed C. albicans than by viable organisms in 26 of the 27 subjects. In marked contrast, IL-1 was induced preferentially by viable C. albicans in 23 of the 27 women. Thus, TNF and IL-1 production induced by C. albicans appears to be non-coordinately regulated and may involve different Candida moieties.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1890562     DOI: 10.1080/02681219180000261

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  11 in total

1.  Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice.

Authors:  M G Netea; P N Demacker; N de Bont; O C Boerman; A F Stalenhoef; J W van der Meer; B J Kullberg
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 2.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  A protective role of platelet-activating factor in murine candidiasis.

Authors:  S Y Im; J H Choi; H M Ko; S J Han; S B Chun; H K Lee; T Y Ha
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

4.  Preincubation of Candida albicans strains with amphotericin B reduces tumor necrosis factor alpha and interleukin-6 release by human monocytes.

Authors:  G Raponi; M C Ghezzi; C Mancini; F Filadoro
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

5.  Radiographic features of experimental Candida arthritis in rats.

Authors:  Y Nakamura; S Noda; T Masuhara; S Ito-Kuwa; K Nakamura; S Aoki
Journal:  Mycopathologia       Date:  1993-02       Impact factor: 2.574

6.  In vitro modulation of keratinocyte-derived interleukin-1 alpha (IL-1 alpha) and peripheral blood mononuclear cell-derived IL-1 beta release in response to cutaneous commensal microorganisms.

Authors:  C E Walters; E Ingham; E A Eady; J H Cove; J N Kearney; W J Cunliffe
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

7.  The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-alpha from human and murine macrophages.

Authors:  T Jouault; A Bernigaud; G Lepage; P A Trinel; D Poulain
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

Review 8.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

9.  Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis.

Authors:  A Louie; A L Baltch; R P Smith; M A Franke; W J Ritz; J K Singh; M A Gordon
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

10.  Biochemical markers predictive of preterm delivery.

Authors:  S R Inglis
Journal:  Infect Dis Obstet Gynecol       Date:  1997
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.